Replies to post #202513 on Elite Pharmaceuticals Inc (ELTP)

[KravMD]

Nas, as a follow up to yesterday's discussion. I've received a response and the webinar is still being edited and will be posted upon it's completion.

I'd post the actual reply but statements like the following preclude me from doing so.


"you are hereby notified that any distribution or copying of this communication is strictly prohibited."